“…However, this body of literature does not consider how increases or decreases of dopamine affect the decision itself, only its latency or speed. Instead, OpAL/OpAL* can capture both shifts in vigor and cost-benefit choice as seen empirically with drug manipulations across species ( Cousins et al, 1996 ; Salamone et al, 2005 ; Treadway et al, 2012 ; Westbrook et al, 2020 ) and more precise optogenetic manipulations of DA and activity of D1 and D2 MSNs ( Doi et al, 2020 ; Bolkan et al, 2022 ; Zalocusky et al, 2016 ; Tai et al, 2012 ; Yartsev et al, 2018 ). Notably, OpAL* suggests that in sparse reward environments, it is adaptive to lower dopaminergic levels and not merely avoiding action altogether (as in classical notions of the direct indirect pathways).…”